China's landscape in regenerative medicine

被引:15
|
作者
Tang, Xin [1 ]
Qin, Hua [2 ]
Gu, Xiaosong [1 ]
Fu, Xiaobing [2 ]
机构
[1] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Coinnovat Ctr Neuroregenerat, Nantong 226001, JS, Peoples R China
[2] Peoples Liberat Army Gen Hosp, PLA Med Coll, Coll Life Sci, Key Lab Tissue Repair & Regenerat PLA, Beijing 100853, Peoples R China
基金
中国国家自然科学基金;
关键词
Regenerative medicine; Tissue engineering; Stem cells; China; Review; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; TREATED DENTIN MATRIX; PLATELET-RICH PLASMA; IMPROVE MYOCARDIAL PERFORMANCE; BONE MORPHOGENETIC PROTEIN-2; IN-UTERO TRANSPLANTATION; FIBROBLAST-GROWTH-FACTOR; TISSUE-ENGINEERED BONE; ACELLULAR NERVE GRAFT;
D O I
10.1016/j.biomaterials.2017.01.044
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Regenerative medicine is a burgeoning interdisciplinary research field that can impact healthcare by offering new therapeutic strategies to replace or regenerate human cells, tissues, or organs with the ultimate goal of restoring or establishing normal human functions. The past decade has seen significant progress of regenerative medicine in China, the world's most populous developing country. With government backing, the progress in regenerative medicine is driven by increasing medical demands of people, accompanied by the economic growth, population aging, and lifestyle change in China. Although regenerative medicine encompasses many components, tissue engineering and stem cell technology are generally considered the two key players. In this review article, we outline the representative achievements in the research and application of tissue engineering, stem cell technology, and other regenerative medical strategies attained by various research groups in China, and highlight the major contributions and features of several outstanding studies made by leading Chinese researchers. Where possible, we discuss the unique opportunities and challenges for advancement of regenerative medicine in China. It is our hope that this review will stimulate new research directions for regenerative medicine in general, and encourage strategic collaborations between the east and the west in particular, so that the clinical translation of regenerative medicine can be accelerated to benefit mankind. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:78 / 94
页数:17
相关论文
共 50 条
  • [1] Regulatory Landscape of Regenerative Medicine in Japan
    Azuma, Kentaro
    [J]. CURRENT STEM CELL REPORTS, 2015, 1 (02) : 118 - 128
  • [2] The evolving regulatory landscape in regenerative medicine
    Beetler, Danielle J.
    Di Florio, Damian N.
    Law, Ethan W.
    Groen, Chris M.
    Windebank, Anthony J.
    Peterson, Quinn P.
    Fairweather, DeLisa
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2023, 91
  • [3] Reprogramming and Transdifferentiation Shift the Landscape of Regenerative Medicine
    Guo, Jingjing
    Wang, Hu
    Hu, Xingchang
    [J]. DNA AND CELL BIOLOGY, 2013, 32 (10) : 565 - 572
  • [4] Regenerative medicine: the present's medicine
    Alatrista, German Rossani
    Patino, Ivan Hernandez
    Casado, Fanny L.
    Vargas, Jhony A. De la Cruz
    [J]. CYTOTHERAPY, 2021, 23 (03) : 185 - 185
  • [5] Cultivating regenerative medicine innovation in China
    McMahon, Dominique S.
    Thorsteindottir, Halla
    Singer, Peter A.
    Daar, Abdallah S.
    [J]. REGENERATIVE MEDICINE, 2010, 5 (01) : 35 - 44
  • [6] Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine
    Tobita, Morikuni
    Konomi, Kenji
    Torashima, Yasuhiro
    Kimura, Kenichi
    Taoka, Masaomi
    Kaminota, Masahiro
    [J]. REGENERATIVE THERAPY, 2016, 4 : 78 - 81
  • [7] Regenerative medicine in China: demands, capacity, and regulation
    Cheng, Biao
    Lu, Shuliang
    Fu, Xiaobing
    [J]. BURNS & TRAUMA, 2016, 4
  • [8] Stem cell therapies and regenerative medicine in China
    Sha Huang
    XiaoBing Fu
    [J]. Science China Life Sciences, 2014, 57 : 157 - 161
  • [9] Stem cell therapies and regenerative medicine in China
    HUANG Sha
    FU XiaoBing
    [J]. Science China Life Sciences, 2014, 57 (02) : 157 - 161
  • [10] Stem cell therapies and regenerative medicine in China
    Huang Sha
    Fu XiaoBing
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2014, 57 (02) : 157 - 161